ArticleCell death & disease2020

FBI-1 enhanced the resistance of triple-negative breast cancer cells to chemotherapeutic agents via the miR-30c/PXR axis.

Hua Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.